Variant report
Variant | nsv981945 |
---|---|
Chromosome Location | chr8:61300219-61301418 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:61296490..61298553-chr8:61300202..61301762,2 | K562 | blood: | |
2 | chr8:61193005..61195471-chr8:61301393..61304721,3 | K562 | blood: | |
3 | chr8:61300352..61302588-chr8:61303599..61306089,2 | K562 | blood: | |
4 | chr8:61296490..61298553-chr8:61300202..61301849,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000178538 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs377271426 | chr8:61300265-61300266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549295161 | chr8:61300272-61300273 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368545728 | chr8:61300290-61300291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73250102 | chr8:61300307-61300308 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs185199612 | chr8:61300372-61300373 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546156567 | chr8:61300373-61300374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs73251503 | chr8:61300389-61300390 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs563568815 | chr8:61300390-61300391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547133582 | chr8:61300430-61300431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189900172 | chr8:61300467-61300468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574247619 | chr8:61300480-61300481 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs10957133 | chr8:61300510-61300511 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs548346243 | chr8:61300527-61300528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs141090672 | chr8:61300568-61300569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182611586 | chr8:61300599-61300600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188361946 | chr8:61300603-61300604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551909603 | chr8:61300711-61300712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs16926111 | chr8:61300734-61300735 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs534613877 | chr8:61300747-61300748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553126827 | chr8:61300756-61300757 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150200765 | chr8:61300795-61300796 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535539091 | chr8:61300811-61300812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557060484 | chr8:61300838-61300839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575353907 | chr8:61300862-61300863 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs191555822 | chr8:61300885-61300886 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564333229 | chr8:61300896-61300897 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs80007886 | chr8:61300928-61300929 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540618287 | chr8:61300948-61300949 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547255117 | chr8:61300964-61300965 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571795373 | chr8:61300970-61300971 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs562258198 | chr8:61300972-61300973 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147876527 | chr8:61301000-61301001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548287994 | chr8:61301086-61301087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563345944 | chr8:61301101-61301102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs530537110 | chr8:61301138-61301139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371123916 | chr8:61301179-61301180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570397137 | chr8:61301180-61301181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs141690413 | chr8:61301195-61301196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs546612147 | chr8:61301215-61301216 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567892479 | chr8:61301243-61301244 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535243320 | chr8:61301262-61301263 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556751906 | chr8:61301278-61301279 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374310357 | chr8:61301302-61301303 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs575295026 | chr8:61301316-61301317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539554538 | chr8:61301385-61301386 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs4145666 | chr8:61301410-61301411 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs573197027 | chr8:61301417-61301418 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Schizophrenia | 23813976 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:61297000-61301000 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
2 | chr8:61298600-61300800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
3 | chr8:61300200-61302000 | Enhancers | HUVEC | blood vessel |
4 | chr8:61300400-61302600 | Enhancers | HMEC | breast |
5 | chr8:61300800-61301000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr8:61300800-61301400 | Enhancers | NHEK | skin |
7 | chr8:61300800-61302400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr8:61300800-61302800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr8:61301000-61301200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
10 | chr8:61301000-61301800 | Enhancers | Fetal Kidney | kidney |
11 | chr8:61301000-61302200 | Enhancers | Brain Germinal Matrix | brain |
12 | chr8:61301000-61302800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
13 | chr8:61301200-61301800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |